The molecule and its receptor CCR5 have been associated with a variety of neuropathological conditions, including multiple sclerosis, stroke and Parkinson’s disease [46, 55, 56]; however, the definitive role of RANTES in the diseased CNS remains unclear [57]. Here, CCL5 is linked to Parkinson disease.